$75.52
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Intra-Cellular Therapies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Intra-Cellular Therapies using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $-0.16 | $-0.19 | 15.8 % |
Mar 2024 | 2024-05-07 | $-0.16 | $-0.33 | 51.5 % |
Dec 2023 | 2024-02-22 | $-0.30 | $-0.43 | 30.2 % |
Sep 2023 | 2023-11-02 | $-0.25 | $-0.56 | 55.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $161.39M | $157.88M | 2.22 % |
Mar 2024 | 2024-05-07 | $144.87M | $140.91M | 2.81 % |
Dec 2023 | 2024-02-22 | $132.10M | $136.79M | -3.43 % |
Sep 2023 | 2023-11-02 | $126.17M | $119.35M | 5.72 % |
Intra-Cellular Therapies (ITCI) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 7, 2024 for Q2.
The Actual EPS was $-0.16, which beat the estimate of $-0.19.
The Actual Revenue was $161.4M, which beat the estimate of $157.9M.
Browse earnings estimates, EPS, and revenue on all stocks.